164 related articles for article (PubMed ID: 30421588)
1. Clinical Course and Treatment Response of Neuromyelitis Optica Spectrum Disease: An 8-Year Experience.
Lin CW; Lin IH; Chen TC; Jou JR; Woung LC
Asia Pac J Ophthalmol (Phila); 2019; 8(3):206-210. PubMed ID: 30421588
[TBL] [Abstract][Full Text] [Related]
2. Different alteration patterns of sub-macular choroidal thicknesses in aquaporin-4 immunoglobulin G antibodies sero-positive neuromyelitis optica spectrum diseases and isolated optic neuritis.
Peng C; Li L; Yang M; Teng D; Wang J; Lai M; Qian H; Li H; Zhou H; Xu Q; Wei S
Acta Ophthalmol; 2020 Dec; 98(8):808-815. PubMed ID: 32657009
[TBL] [Abstract][Full Text] [Related]
3. Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders.
Song W; Qu Y; Huang X
Int Ophthalmol; 2019 Nov; 39(11):2477-2483. PubMed ID: 30825049
[TBL] [Abstract][Full Text] [Related]
4. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.
Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P
Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029
[TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis Optica Spectrum Disorder: Disease Course and Long-Term Visual Outcome.
Brody J; Hellmann MA; Marignier R; Lotan I; Stiebel-Kalish H
J Neuroophthalmol; 2016 Dec; 36(4):356-362. PubMed ID: 27348750
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and long-term visual outcome of optic neuritis in neuromyelitis optica spectrum disorder: A comparison between Thai and American-Caucasian cohorts.
Vanikieti K; Poonyathalang A; Jindahra P; Bouzika P; Rizzo JF; Cestari DM
Mult Scler Relat Disord; 2017 Oct; 17():87-91. PubMed ID: 29055481
[TBL] [Abstract][Full Text] [Related]
7. Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.
Nishimura H; Enokida H; Sakamoto T; Takahashi T; Hayami H; Nakagawa M
J Artif Organs; 2018 Sep; 21(3):378-382. PubMed ID: 29675599
[TBL] [Abstract][Full Text] [Related]
8. A prospective case-control study comparing optical coherence tomography characteristics in neuromyelitis optica spectrum disorder- optic neuritis and idiopathic optic neuritis.
Zhao X; Qiu W; Zhang Y; Luo Y; Zhang X; Lu L; Yang H
BMC Ophthalmol; 2018 Sep; 18(1):247. PubMed ID: 30217177
[TBL] [Abstract][Full Text] [Related]
9. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
Pache F; Zimmermann H; Mikolajczak J; Schumacher S; Lacheta A; Oertel FC; Bellmann-Strobl J; Jarius S; Wildemann B; Reindl M; Waldman A; Soelberg K; Asgari N; Ringelstein M; Aktas O; Gross N; Buttmann M; Ach T; Ruprecht K; Paul F; Brandt AU;
J Neuroinflammation; 2016 Nov; 13(1):282. PubMed ID: 27802824
[TBL] [Abstract][Full Text] [Related]
10. Distinct clinical characteristics of atypical optic neuritis with seronegative aquaporin-4 antibody among Chinese patients.
Zhou H; Xu Q; Zhao S; Wang W; Wang J; Chen Z; Lin D; Li X; Peng C; Ai N; Wei S
Br J Ophthalmol; 2017 Dec; 101(12):1720-1724. PubMed ID: 28404667
[TBL] [Abstract][Full Text] [Related]
11. [Effects of intravenous methylprednisolone pulse therapy on optic neuritis associated with AQP4 antibody seropositive neuromyelitis optica].
Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB
Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):180-185. PubMed ID: 30841684
[No Abstract] [Full Text] [Related]
12. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
13. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
[TBL] [Abstract][Full Text] [Related]
14. Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders.
Mori S; Kurimoto T; Ueda K; Nakamura M
Jpn J Ophthalmol; 2018 Jul; 62(4):525-530. PubMed ID: 29802557
[TBL] [Abstract][Full Text] [Related]
15. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.
Merle H; Olindo S; Jeannin S; Valentino R; Mehdaoui H; Cabot F; Donnio A; Hage R; Richer R; Smadja D; Cabre P
Arch Ophthalmol; 2012 Jul; 130(7):858-62. PubMed ID: 22776923
[TBL] [Abstract][Full Text] [Related]
16. Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.
Palace J; Lin DY; Zeng D; Majed M; Elsone L; Hamid S; Messina S; Misu T; Sagen J; Whittam D; Takai Y; Leite MI; Weinshenker B; Cabre P; Jacob A; Nakashima I; Fujihara K; Pittock SJ
Brain; 2019 May; 142(5):1310-1323. PubMed ID: 30938427
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
Kitley J; Leite MI; Nakashima I; Waters P; McNeillis B; Brown R; Takai Y; Takahashi T; Misu T; Elsone L; Woodhall M; George J; Boggild M; Vincent A; Jacob A; Fujihara K; Palace J
Brain; 2012 Jun; 135(Pt 6):1834-49. PubMed ID: 22577216
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Visual Prognosis in Patients With Aquaporin-4-Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder.
Moon Y; Jang Y; Lee HJ; Kim SM; Kim SJ; Jung JH
J Neuroophthalmol; 2022 Sep; 42(3):303-309. PubMed ID: 35427249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
